Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Stanford University
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
University College, London
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Genmab
Stanford University
Genmab
Thomas Jefferson University
Mayo Clinic
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Rochester General Hospital
Fred Hutchinson Cancer Center
Northwestern University
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Neumedicines Inc.
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)